The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 342:344-345 February 3, 2000 Number 5
NextNext

Rapid-Onset Type 1 Diabetes with Pancreatic Exocrine Dysfunction

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Imagawa, A.
-PubMed Citation
We tend to view type 1 diabetes mellitus as a chronic autoimmune disease with a preclinical phase that usually lasts for a number of years.1 The classic symptoms of type 1 diabetes — hyperglycemia and ketosis — are thought to occur late in its course, only after 80 to 90 percent of the beta cells of the pancreatic islets have been destroyed. Data that provide strong support for this view have been obtained in numerous prospective studies of first-degree relatives of patients with type 1 diabetes; the relatives were followed because they had islet-cell antibodies.2 The conventional view of autoimmune . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.